Kodiak Sciences (KOD) Treasury Shares (2017 - 2026)
Kodiak Sciences' (KOD) quarterly Treasury Shares came in at $120820.0 in Q4 2025, little changed YoY from $120820.0 in Q4 2024, and down 12.73% on a QoQ basis from $138451.0 in Q3 2025.
Kodiak Sciences (KOD) Treasury Shares (2017 - 2026) Analysis & Trends
Kodiak Sciences (KOD) has 9 years of Treasury Shares data on file, last reported at $120820.0 in Q4 2025.
- Quarterly Treasury Shares changed 0.0% year-over-year to $120820.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $120820.0 (changed 0.0% YoY) and the FY2025 annual result came in at $120820.0, changed 0.0% from the prior year.
- Treasury Shares retreated to $120820.0 in Q4 2025, from $138451.0 in the prior quarter.
- In the past five years, Treasury Shares ranged from a high of $412287.0 in Q3 2021 to a low of $117892.0 in Q2 2025.
- A 5-year average of $227141.7 and a median of $199622.0 in 2023 frame the typical range for Treasury Shares.
- Annual changes were most pronounced in 2021 — Treasury Shares jumped 138.8% — and 2024, when it sank 46.0%.
- Tracing KOD's Treasury Shares over 5 years: stood at $363930.0 in 2021, then decreased by 22.92% to $280522.0 in 2022, then slumped by 41.25% to $164817.0 in 2023, then declined by 26.69% to $120820.0 in 2024, then changed by 0.0% to $120820.0 in 2025.
- The last three Treasury Shares figures came in at $120820.0 (Q4 2025), $138451.0 (Q3 2025), and $117892.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | Kodiak Sciences | 2.60 Bn | 2.60 Bn | - | 126,751.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 126,751.00 |
| Jun 30, 2026 | 126,751.00 |
| Dec 31, 2025 | 120,820.00 |
| Dec 31, 2025 | 120,820.00 |
| Sep 30, 2025 | 138,451.00 |
| Sep 30, 2025 | 138,451.00 |
| Jun 30, 2025 | 117,892.00 |
| Jun 30, 2025 | 117,892.00 |
| Mar 31, 2025 | 133,253.00 |
| Mar 31, 2025 | 133,253.00 |
| Dec 31, 2024 | 120,820.00 |
| Dec 31, 2024 | 120,820.00 |
| Sep 30, 2024 | 122,349.00 |
| Sep 30, 2024 | 122,349.00 |
| Jun 30, 2024 | 127,521.00 |
| Jun 30, 2024 | 127,521.00 |
| Mar 31, 2024 | 151,716.00 |
| Mar 31, 2024 | 151,716.00 |
| Dec 31, 2023 | 164,817.00 |
| Dec 31, 2023 | 164,817.00 |